Pharma and healthcare company Abbott is putting its media agency assignment into review.
The company spent about $120 million on ads in 2014 and $70 million in the first half of 2015 according to Kantar Media.
Incumbent Mindshare is expected to defend although agency officials couldn’t immediately be reached for comment.
Asked about the review, an Abbott rep responded in an email, “We don’t have any comment on the matter.”
In addition to pharmaceuticals, the company markets a range of medical diagnostic equipment, vascular devices, as well as products related to nutrition, diabetes and vision care.
Among Abbott’s roster of brands are Pedialyte, Ensure and Similac.
In 2013, Abbott spun off a pharmaceutical unit called AbbVie that at the time marketed brand name drugs such as Humira, used to treat rheumatoid arthritis and a prostate cancer drug Lupron among others.
Soon after the spinoff AbbVie held a media review that was won by SMG’s Spark. The spinoff remains a separate company and is not part of the Abbott review.